Jessica Grossman, M.D., is a fan of the calculated risk. Taking one to change careers after medical school landed her in a role that is helping shape the future of women’s healthcare.
FDA Approves Medicines360’s sNDA for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years
Approval Offers Women Additional Flexibility for Pregnancy Prevention DUBLIN and SAN FRANCISCO – Allergan plc (NYSE:AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women’s health pharmaceutical company with a mission of expanding access to quality medicines, announced that the U.S. Food and Drug Administration (FDA) approved Medicines360’s Supplemental New Drug Application (sNDA) to extend the duration of use […]
Jessica Grossman, M.D., CEO of Medicines360, Wants to Make Sure Women Have Reproductive Healthcare Choices
Jessica Grossman, M.D., CEO of Medicines360, wants to empower women when it comes to choices surrounding their reproductive healthcare.